The Schwab U.S. Dividend Equity ETF (SCHD) tracks the Dow Jones U.S. Dividend 100 Index, which selects around 100 high-dividend-yielding U.S. companies based on consistent dividend payments and key fundamental metrics such as cash flow-to-debt and return on equity (ROE). In my view, this rules-based approach stands out because it prioritizes dividend sustainability and growth rather than chasing the highest yields alone, giving investors exposure to financially robust large-cap value stocks.
SCHD's holdings are heavily concentrated in the United States (over 95%), with sector diversification across consumer defensive (~19%), healthcare (~19%), energy (~17%), industrials (~11%), and information technology (~11%). As of early 2026, top holdings include Chevron (CVX) at 4.4%, ConocoPhillips (COP) at 4.3%, Merck (MRK) at 4.2%, Coca-Cola (KO) at 4.1%, and Texas Instruments (TXN) at 4.1%. The recent reconstitution brought in names like UnitedHealth (UNH) and Qualcomm (QCOM), which I see as adding to the ETF's quality and growth potential.
From what I see, this setup positions SCHD well for the long haul, with quality dividend payers that hold up in volatile markets, an ultra-low expense ratio of 0.06%, and assets under management over $85 billion. That combination supports tax efficiency and scalability for portfolios balancing income and moderate growth.
Several factors could shape SCHD's path ahead. The March 2026 index reconstitution—the largest in its history—cut energy weighting by about 7-8% while lifting healthcare and tech exposure, focusing on stocks with 60%+ five-year dividend growth rates, well above those that were trimmed. This built-in "buy low, sell high" dynamic seems poised to help sustain yield growth through sector shifts.
With Federal Reserve rate cuts expected 2-3 times through 2026, we could see a steeper yield curve that benefits financials and eases borrowing costs for consumer staples and healthcare holdings. Energy prices remain unpredictable due to geopolitical tensions, which could impact leaders like CVX and COP.
Recent inflows topping $15 billion underscore demand for dividend strategies, which may bolster price stability. I also checked upcoming earnings from key holdings like pharma giants MRK and UNH, where operational efficiencies and AI-driven healthcare innovations could influence flows and rebalances.
The Dow Jones U.S. Dividend 100 Index underpinning SCHD emphasizes quality factors, which aligns nicely with a macro backdrop of moderate U.S. GDP growth (2-2.6%) and Fed easing. Falling rates should make dividend stocks more attractive relative to bonds while supporting spending in staples like KO and PepsiCo (PEP).
Healthcare, at ~19% of the portfolio, stands to gain from tech advances and efficiencies, while energy (~17%) is linked to commodity cycles and supply risks. Consumer staples add defensiveness against lingering inflation, and new tech additions like QCOM provide AI exposure without excessive growth risks. Financials may benefit from deregulation and a steeper curve, though credit issues warrant caution. Overall, the index's strong fundamentals should offer resilience as markets rotate toward value.
Tickeron’s Trend Prediction Engine is an AI-powered tool I rely on to forecast whether assets like SCHD might trend bullish, bearish, or sideways over the next week or month. It processes massive datasets to detect emerging trends, potential breakouts or reversals, and generates predictions for thousands of instruments, including major ETFs. With searchable categories, historical pattern matching, and customizable alerts for high-probability moves, it's invaluable for both short-term trading and long-term positioning amid volatility. In my analysis of SCHD, I've found it sharpens my view on ETF trends—worth exploring to bolster your own forecasts.
This is important because SCHD's outlook ties into lasting themes like demographic pressures boosting healthcare demand and reliable consumer staples usage, reinforced by the index's dividend growth focus. Energy holdings reflect global transition trends, while industrials tap AI infrastructure and capex cycles. As economic cycles favor quality over speculation and rates normalize, SCHD's low-volatility profile should shine.
Holdings like Lockheed Martin (LMT) in defense and Home Depot (HD) in housing-related areas capture policy-backed growth. Broader shifts toward income amid aging populations further support SCHD's ~3.4% yield and compounding power, rooted in the Dow Jones U.S. Dividend 100 Index's track record.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 273 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 53 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.
SCHD moved below its 50-day moving average on September 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SCHD crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for SCHD entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue